...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

** Apabetalone (RVX-208) Currently Being Tested in a Phase 3 BETonMACE Cardiovascular Outcomes Trial ** BETonMACE Trial is Fully Enrolled and Top-Line Data Expected Mid-Year 2019 https://clinicaltrials.gov/ct2/show/NCT02586155

Free
Message: BETonMACE Enrollment
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Bear,

Thanks for the reading assignement. I do recall now that BETonMACE did exclude patients with ALT/AST levels greater than 1.5 the upper limits.

Interesting to see where the liver research takes us. This opens up a whole new market.

CD

1 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply